- George S. Pepper Professor of Public Health and Preventive Medicine
- Professor of Medicine
- Professor of Pharmacology
- Chair and Professor, Department of Biostatistics and Epidemiology
- Director, Center for Clinical Epidemiology and Biostatistics
- Vice Dean for Institutional Affairs
- Senior Advisor to the Provost for Global Health Initiatives
Dr. Strom earned a B.S. in Molecular Biophysics and Biochemistry from Yale University in 1971, and then an M.D. degree from the Johns Hopkins University School of Medicine in 1975. From 1975-1978 he was an intern and resident in Internal Medicine and from 1978-1980 he was an NIH fellow in Clinical Pharmacology at the University of California, San Francisco. He simultaneously earned an M.P.H. Degree in Epidemiology at the University of California, Berkeley. He has been on the faculty of the University of Pennsylvania School of Medicine since 1980. The Center for Clinical Epidemiology and Biostatistics that he has created at Penn includes over 550 faculty, research and support staff, and trainees. CCEB research currently receives over $49 million/year in extramural support. More than 500 clinicians have been trained or are in training through the CCEB’s Master of Science in Clinical Epidemiology degree program. All but approximately 50 have appointments in academic or other research institutions. In this process, Dr. Strom has become a leader in the rigorous formal training of clinical researchers.
Although Dr. Strom's interests span many areas of clinical epidemiology, his major research interest is in the field of pharmacoepidemiology, i.e., the application of epidemiologic methods to the study of drug use and effects. He is editor of the field's major text (now going into its fifth edition), and is now Editor-in-Chief for Pharmacoepidemiology and Drug Safety, the official journal of the International Society for Pharmacoepidemiology. In addition to writing more than 525 papers, he has been principal investigator for more than 240 grants, including over $73 million in direct costs alone. Dr. Strom has also made substantial contributions to many additional extramurally-funded grants. Recent grants include an NCI Program Project Grant on Molecular Susceptibility to Hormone-Induced Cancers, awards from the Agency for Health Care Research and Quality for a Center for Research and Education on Therapeutics (CERTs), a Center of Excellence for Patient Safety Research and Practice, and a center within the Developing Evidence to Inform Decisions About Effectiveness (DEcIDE) Network. He has been invited to more than 375 talks outside his local area, including being the keynote speaker for numerous international meetings. Dr. Strom has been a consultant to NIH, FDA, CDC, USP, AAMC, JCAHO, foreign governments, most major pharmaceutical manufacturers, and many law firms.